Related content

Pancreatic cancer immunotherapy using a tumor lysate vaccine, engineered to express α-gal epitopes, targets pancreatic cancer stem cells

By  

International Journal of Oncology, Vol. 46, Iss. 1, 2015-01 ,pp. : 78-90

Spandidos Publications

Access to resources Recommend Favorite

Expression of -gal epitopes on ovarian carcinoma membranes to be used as a novel autologous tumor vaccine

By Galili U.   Chen Z.-c.   DeGeest K.  

Gynecologic Oncology, Vol. 90, Iss. 1, 2003-07 ,pp. : 100-108

Elsevier

Access to resources Recommend Favorite

Tumor Vaccines for Breast Cancer

By Anderson Karen  

Cancer Investigation, Vol. 27, Iss. 4, 2009-05 ,pp. : 361-368

Informa Healthcare

Access to resources Recommend Favorite

Combination of monocyte-derived dendritic cells and activated T cells which express CD40 ligand: a new approach to cancer immunotherapy

By Sato Takami   Terai Mizue   Yasuda Rie   Watanabe Ryuko   Berd David   Mastrangelo Michael   Hasumi Kenichiro  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 1, 2004-01 ,pp. : 53-61

Springer Publishing Company

Access to resources Recommend Favorite

Advanced breast cancer: anti-progressive immunotherapy using a thermostable autologous hemoderivative

By Lasalvia-Prisco Eduardo   Vázquez Jesús   Golomar Wilson   Larrañaga Joshemaria   Garcia-Giralt Emilio   Cucchi Silvia   Lasalvia-Galante Eduardo  

Breast Cancer Research and Treatment, Vol. 100, Iss. 2, 2006-11 ,pp. : 149-160

Springer Publishing Company

Access to resources Recommend Favorite